Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621875 | PMC |
| http://dx.doi.org/10.4102/ajlm.v13i1.2645 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The scourge of antimicrobial resistance: Containing a global crisis.
Afr J Lab Med
November 2024
Department of Pathology, University of Botswana, Gaborone, Botswana.
Cholera is a dreadful disease. The scourge of this deadly disease is still evident in the developing world. Though several therapeutic strategies are in practice to combat and contain the disease, there is still a need for new drugs to control the disease safely and effectively.
View Article and Find Full Text PDFDual SARS-CoV-2 and MERS-CoV inhibitors from : isolation, structure elucidation, molecular modelling studies, and activities.
Org Biomol Chem
August 2024
Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
The COVID-19 pandemic has spread throughout the whole globe, so it is imperative that all available resources be used to treat this scourge. In reality, the development of new pharmaceuticals has mostly benefited from natural products. The widespread medicinal usage of species in the Asteraceae family is extensively researched.
View Article and Find Full Text PDFPredictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review.
Ann Afr Med
April 2024
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria.
Background Information: Over 1.6 million Nigerians have succumbed to the ravaging scourge of the acquired immunodeficiency syndrome (AIDS) epidemic since its discovery. Viral suppression (VS) then becomes a critical cost-effective human immunodeficiency virus (HIV) prevention strategy.
View Article and Find Full Text PDFExploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors.
Bioorg Chem
February 2024
Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (LSPCMIB), UMR 5068, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France. Electronic address:
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a worldwide scourge with more than 10 million people affected yearly. Among the proteins essential for the survival of Mtb, InhA has been and is still clinically validated as a therapeutic target. A new family of direct diaryl ether inhibitors, not requiring prior activation by the catalase peroxidase enzyme KatG, has been designed with the ambition of fully occupying the InhA substrate-binding site.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!